CMPI.org

In the News

Surgeon General advises more to carry NARCAN

04/05/2018 12:00 AM | i24NEWS

Advancing Drug Safety Through Prospective Pharmacovigilance

04/01/2018 12:00 AM | Therapeutic Innovation & Regulatory Science Journal

Understanding FDA's Blueprint for Transparency

03/26/2018 12:00 AM | Medical Marketing & Media

On Drug Prices, President Trump Knows Better Than Candidate Donald

03/09/2018 12:00 AM | Investor's Business Daily

To cut drug prices, start with the facts

03/09/2018 12:00 AM | Deseret News

The Solution to Drug Pricing? Don’t Fix the Blame, Fix the Problem.

03/06/2018 12:00 AM | Morning Consult

A new NAFTA deal must halt intellectual property theft

03/01/2018 12:00 AM | Washington Examiner

Value of Medicines: The value equation

02/16/2018 12:00 AM | PharmaLive

Trump’s FDA Pick Is Speeding Up New Drug Approvals

02/02/2018 12:00 AM | Newsweek

These Companies Want You to Sell Your DNA on the Internet

01/18/2018 12:00 AM | Gizmodo

Principles for PBM Reform and Patient Centered Prescription Drug Benefits

12/20/2017 12:00 AM | CMPI & NCPA

How PBMs Affect Access and Affordability

12/20/2017 12:00 AM | CMPI & NCPA

Keynote Speech: A. Mark Fendrick, M.D.

12/20/2017 12:00 AM | CMPI & NCPA

CMPI Report: Principles for Patient-Centered Prescription Drug Coverage

12/20/2017 12:00 AM | CMPI & NCPA

Patients vs PBMs: The Movie

07/14/2017 12:00 AM | CMPI

CMPI President Peter J. Pitts discusses the Opioid Crisis on i24NEWS

06/12/2017 12:00 AM | i24NEWS

Regenerative Medicine Can Help Make America Great

06/12/2017 12:00 AM | Morning Consult

Managed Care Magazine Launches Attack on Orphans

06/09/2017 12:00 AM | LinkedIn

When it comes to faster access to drugs, first do no harm

06/04/2017 12:00 AM | The Hill

The False Promise of Drug-Price Controls

05/19/2017 12:00 AM | National Review

Previous
1
...
5
6
7
8
9
10
11
Next

RECENT NEWS

The coronavirus could help pharma reset its reputation in Washington

STAT
03/03/2020 12:00 AM

The coronavirus could help pharma reset its reputation in Washington

The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington.... Read more

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

STAT
10/17/2024 12:00 AM

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub... Read more

Tort bar’s newest collateral damage: Preterm babies

The Washington Times
07/02/2024 12:00 AM

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers... Read more

Read all News